前列腺三维磁共振波谱的临床初步研究

征锦, 陈文新, 凌俊, 陈娟, 王双龙

征锦, 陈文新, 凌俊, 陈娟, 王双龙. 前列腺三维磁共振波谱的临床初步研究[J]. 实用临床医药杂志, 2005, (3): 64-66. DOI: 10.3969/j.issn.1672-2353.2005.03.022
引用本文: 征锦, 陈文新, 凌俊, 陈娟, 王双龙. 前列腺三维磁共振波谱的临床初步研究[J]. 实用临床医药杂志, 2005, (3): 64-66. DOI: 10.3969/j.issn.1672-2353.2005.03.022
ZHENG Jin, CHEN Wen-xin, LING Jun, CHEN Luan, WANG Shuang-long. THREE DIMENSIONAL (H MR SPECTROSCOPIC IMAGING) OF THE PROSTATE PRELIMINARY RESULTS[J]. Journal of Clinical Medicine in Practice, 2005, (3): 64-66. DOI: 10.3969/j.issn.1672-2353.2005.03.022
Citation: ZHENG Jin, CHEN Wen-xin, LING Jun, CHEN Luan, WANG Shuang-long. THREE DIMENSIONAL (H MR SPECTROSCOPIC IMAGING) OF THE PROSTATE PRELIMINARY RESULTS[J]. Journal of Clinical Medicine in Practice, 2005, (3): 64-66. DOI: 10.3969/j.issn.1672-2353.2005.03.022

前列腺三维磁共振波谱的临床初步研究

详细信息
  • 中图分类号: R737.25

THREE DIMENSIONAL (H MR SPECTROSCOPIC IMAGING) OF THE PROSTATE PRELIMINARY RESULTS

  • 摘要: 目的评价三维磁共振波谱成像(three-dimensional MR spectroscopic imaging, 3D MRSI)联合MRI对鉴别前列腺癌和良性前列腺增生的价值.方法对15例临床疑有前列腺癌患者行MRI和3D MRSI检查,并将3D MRSI检查结果与手术病理结果对照.结果 15例患者全部顺利完成3D增长MRSI检查,其中良性前列腺增生4例、前列腺癌11例,良性前列腺增生的枸橼酸盐(citrate, cit)峰位于2.85~3.03 mg/L; 胆碱(choline, cho)+肌酸(creatine,cre)峰值位于0.9~1.67 mg/L; 中央腺体的(cho+cre)/cit在0.48~0.53; 前列腺癌灶区的cit峰值明显降低,位于0.57~0.85 mg/L; cho+cre峰值改变不明显,位于0.86~1.16 mg/L; (cho+cre)/cit比值增大,其比值为1.48~2.03.结论用3D MRSI检查前列腺可得到有意义的谱线,与病理对照研究的初步结果显示3D MRSI有助于鉴别列腺癌和良性前列腺增生,与MRI结合能显示肿瘤范围.
  • 蒋学祥, 王霄英, 肖江喜. 前列腺癌的MR诊断 [J]. 中国医学影像技术, 2001, (9):840.doi: 10.3321/j.issn:1003-3289.2001.09.013.
    Kurhanewicz J, Vigneron D B, Hricak H. Three-dimensional H Spectroscopic Imaging of the in Situ Human Prostate with High(0.24~0.7 cm3) Spatial Resolution [J]. Radiology, 1996.795.
    Landish S H, Marray T, Boldens. CA cancer statistics [J]. CA:A Cancer Journal for Clinicians, 1998.6.
    顾方六. 前列腺癌的流行病学 [J]. 中华泌尿外科杂志, 1997.58.
    王霄英, 周良平, 蒋学祥. 前列腺三维磁共振波谱成像的初步研究 [J]. 中国医学影像技术, 2002, (11):1154.doi: 10.3321/j.issn:1003-3289.2002.11.021.
    Presti JC Jr, Hricak H, Narayan P A. Local staging of prostatic carcinoma: comparision of tromsrectal sonography and endorrectal MR imaging [J]. American Journal of Roentgenology, 1996.103.
    Jager G J, Ruijter E T, Vandekaa C A. Local staging of prostate cancer with endorectal MR imaging correlation with histopathology [J]. American Journal of Roentgenology, 1996.845.
    Hricak H, White S, Vigneron D. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal pelvic phased-array coils [J]. Radiology, 1994.703.
    Scheidler J, Hricak H, Vigneron D. Prostate cancer: Localization with Three-dimonsional proton MR Spectroscopic Imaging Clinicopathology study [J]. Radiology, 1999, (2):473.
    Outwater E K, Petersen R O, SIEGelman E S. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images [J]. Radiology, 1994.333.
    Kurhanewica J, Vigneron D B, Nelson S J. citrate as an in vivo marker to discriminate prostate cancer from benign prostate hyperplasia and normal prostate zone:detection via localized proton spectroscopy [J]. Urology, 1995.459.doi: 10.1016/S0090-4295(99)80016-8.
计量
  • 文章访问数:  104
  • HTML全文浏览量:  19
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 发布日期:  2005-05-18

目录

    /

    返回文章
    返回
    x 关闭 永久关闭